Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “QL1706”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Testing effectiveness (Phase 2)UnknownNCT05329025
What this trial is testing

QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 100
Testing effectiveness (Phase 2)UnknownNCT05603039
What this trial is testing

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Liver Cancer
Qilu Pharmaceutical Co., Ltd. 80
Early research (Phase 1)Not Yet RecruitingNCT06822985
What this trial is testing

QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Wan-Guang Zhang 21
Early research (Phase 1)UnknownNCT04296994
What this trial is testing

QL1706 in Subjects With Advanced Malignant Tumor

Who this might be right for
Advanced Malignant Tumor
Qilu Pharmaceutical Co., Ltd. 99
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07156682
What this trial is testing

QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer

Who this might be right for
Colon CancerMSS/pMMRQL1706
Qilu Hospital of Shandong University 21
Testing effectiveness (Phase 2)UnknownNCT05557565
What this trial is testing

A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Qilu Pharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)UnknownNCT05262413
What this trial is testing

QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC)

Who this might be right for
Advanced Renal Cell Carcinoma
Qilu Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750861
What this trial is testing

QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC

Who this might be right for
Pancreatic Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07091305
What this trial is testing

QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)ChemoradiotherapyInduction Therapy+1 more
Shanghai Chest Hospital 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07246317
What this trial is testing

Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 188
Large-scale testing (Phase 3)Not Yet RecruitingNCT05976568
What this trial is testing

QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Qilu Pharmaceutical Co., Ltd. 668
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07342283
What this trial is testing

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Affiliated Hospital of Nantong University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06786026
What this trial is testing

QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC

Who this might be right for
TNBC, Triple Negative Breast Cancer
Fudan University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07384416
What this trial is testing

Single-Arm Trial of QL1706, Lenvatinib, and Nab-Paclitaxel for Advanced Refractory Penile Cancer

Who this might be right for
Penile Cancer
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07256236
What this trial is testing

SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Fujian Cancer Hospital 89
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06746961
What this trial is testing

Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs Therapy

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
The First Affiliated Hospital of Zhengzhou University 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07396324
What this trial is testing

Neoadjuvant Iparomlimab and Tuvonralimab (QL1706) in Patients With Hormone Receptor Positive, HER2-negative Breast Cancer

Who this might be right for
Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
RenJi Hospital 55
Testing effectiveness (Phase 2)Looking for participantsNCT06892925
What this trial is testing

QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors

Who this might be right for
Biliary Tract Tumors
Eastern Hepatobiliary Surgery Hospital 59
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07229872
What this trial is testing

A Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Fruquintinib in the Treatment of Immunodominant pMMR/MSS Metastatic Colorectal Cancer That Has Failed Second-line or Above Treatment

Who this might be right for
Colorectal Cancer
Harbin Medical University 18
Large-scale testing (Phase 3)UnknownNCT05576272
What this trial is testing

A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Qilu Pharmaceutical Co., Ltd. 460
Load More Results